Cited by 153Tryptophan and brain disordersStress Responses and CortisolTreatment of Major Depression

Immune system dysregulation in adolescent major depressive disorder

Open access
Gabbay, Vilma, Klein, Rachel G., Alonso, Carmen M., Babb, James S., Nishawala, Melissa, De Jesus, Georgette, Hirsch, Glenn S., Hottinger-Blanc, Pauline M.Z. +1 more·2009·Journal of Affective Disorders

Abstract

Background A large body of evidence suggests that immune system dysregulation is associated with Major Depressive Disorder (MDD) in adults. This study extends this work to adolescent MDD to examine the hypotheses of immune system dysregulation in adolescents with MDD, as manifested by significantly: (i) elevated plasma levels of cytokines (interferon [IFN]-gamma, tumor necrosis factor-alpha, interleukin [IL]-6, IL-1beta, and IL-4); and (ii) Th1/Th2 cytokine imbalance shifted toward Th1 as indexed by increased IFN-gamma/IL-4. Method Thirty adolescents with MDD (19 females; 13 medication-free/naïve; ages 12-19) of at least 6 weeks duration and a minimum severity score of 40 on the Children's Depression Rating Scale-Revised, and 15 healthy comparisons (8 females), group-matched for age, were enrolled. Plasma cytokines were examined using enzyme-linked immunosorbent assay. Mann-Whitney test was used to compare subjects with MDD and controls. Results Adolescents with MDD had significantly elevated plasma IFN-gamma levels (3.38+/-11.8 pg/ml versus 0.37+/-0.64 pg/ml; p<0.003), and IFN-gamma/IL-4 ratio (16.6+/-56.5 versus 1.76+/-2.28; p=0.007). A trend for IL-6 to be elevated in the MDD group was also observed (1.52+/-2.88 pg/ml versus 0.49+/-0.90 pg/ml; p=0.09). Importantly, findings remained evident when medicated subjects were excluded. Conclusions Findings suggest that immune system dysregulation may be associated with adolescent MDD, with an imbalance of Th1/Th2 shifted toward Th1, as documented in adult MDD. Larger studies with medication-free adolescents should follow.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jad.2008.07.022

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Individuals with depression show increased production of IFNγ.

    “increased production of IFNγ (Gabbay et al., 2009; Maes et al., 1994)”

    From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Gabbay et al., 2009

    The Results (section 3.2.1; page unavailable) report significantly higher plasma IFN-γ in adolescents with major depressive disorder than in healthy controls. The Methods (section 2.2) show that the study measured plasma concentrations, not IFN-γ production; its direct finding is also limited to adolescents with MDD rather than all individuals with depression. (LLM, conf=0.86)

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 40 · Cited by 153

Research works printed but not linked: 34

  1. Bartlett JA Schleifer SJ Demetrikopoulos MK Keller SE Immune differences in children with and without depression Biol. Psychiatry 1995 38 771 774 8580234
  2. Birmaher B Rabin BS Garcia MR Jain U Whiteside TL Williamson DE al Shabbout M Nelson BC Dahl RE Ryan ND Cellular immunity in depressed, conduct disorder, and normal adolescents: role of adverse life events J. Am. Acad. Child Adolesc. Psych 1994 33 671 678 8056730
  3. Bonaccorso S Marino V Biondi M Grimaldi F Ippoliti F Maes M Depression induced by treatment with interferon-alpha in patients affected by hepatitis C virus J. Affect. Disord 2002 72 237 241 12450640
  4. Brambilla F Monteleone P Maj M Interleukin-1beta and tumor necrosis factor-alpha in children with major depressive disorder or dysthymia J. Affect. Disord 2004 78 273 277 15013254
  5. Connor TJ Leonard BE Depression, stress and immunological activation: the role of cytokines in depressive disorders Life Sci 1998 62 583 606 9472719
  6. Frommberger UH Bauer J Haselbauer P Fraulin A Riemann D Berger M Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission Eur. Arch. Psychiatry Clin. Neurosci 1997 247 228 233 9332905
  7. Fujigaki S Saito K Sekikawa K Tone S Takikawa O Fujii H Wada H Noma A Seishima M Lipopolysaccharide induction of indoleamine 2,3-dioxygenase is mediated dominantly by an IFN-gamma-independent mechanism Eur. J. Immunol 2001 31 2313 2318 11477543
  8. Goodman E Whitaker RC A prospective study of the role of depression in the development and persistence of adolescent obesity Pediatrics 2002 110 497 504 12205250
  9. Huang TL Lee CT T-helper 1/T-helper 2 cytokine imbalance and clinical phenotypes of acute-phase major depression Psychiatry Clin. Neurosci 2007 61 415 420 17610667
  10. Irwin MR Miller AH Depressive disorders and immunity: 20 years of progress and discovery Brain Behav. Immun 2007 21 374 383 17360153
  11. Kapczinski F Vieta E Andreazza AC Frey BN Gomes FA Tramontina J Kauer-Sant’anna M Grassi-Oliveira R Post RM Allostatic load in bipolar disorder: implications for pathophysiology and treatment Neurosci. Biobehav. Rev 2008 32 675 692 18199480
  12. Kaufman J Birmaher B Brent D Rao U Flynn C Moreci P Williamson D Ryan N Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data J. Am. Acad. Child Adolesc. Psych 1997 36 980 988 9204677
  13. Kim YK Na KS Shin KH Jung HY Choi SH Kim JB Cytokine imbalance in the pathophysiology of major depressive disorder Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2007 31 1044 1053 17433516
  14. Kubera M Lin AH Kenis G Bosmans E van Bockstaele D Maes M Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio J. Clin. Psychopharmacol 2001 21 199 206 11270917
  15. Kupfer DJ The increasing medical burden in bipolar disorder Jama 2005 293 2528 2530 15914754
  16. Maes M Meltzer H Bloom F Kupfer D The serotonin hypothesis of major depression Psychopharmacology: The Fourth Generation of Progress 1995 New York Raven Press 933 944
  17. Maes M Scharpe S Meltzer HY Okayli G Bosmans E D’Hondt P Vanden Bossche BV Cosyns P Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response Psychiatry Res 1994 54 143 160 7761549
  18. Maes M Bosmans E De Jongh R Kenis G Vandoolaeghe E Neels H Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression Cytokine 1997 9 853 858 9367546
  19. Maes M Song C Lin AH Bonaccorso S Kenis G De Jongh R Bosmans E Scharpe S Negative immunoregulatory effects of antidepressants: inhibition of interferon-gamma and stimulation of interleukin-10 secretion Neuropsychopharmacology 1999 20 370 379 10088138
  20. Morikawa O Sakai N Obara H Saito N Effects of interferon-alpha, interferon-gamma and cAMP on the transcriptional regulation of the serotonin transporter Eur. J. Pharmacol 1998 349 317 324 9671113
  21. Musselman DL Lawson DH Gumnick JF Manatunga AK Penna S Goodkin RS Greiner K Nemeroff CB Miller AH Paroxetine for the prevention of depression induced by high-dose interferon alfa N. Engl. J. Med 2001 344 961 966 11274622
  22. Pavon L Sandoval-Lopez G Eugenia Hernandez M Loria F Estrada I Perez M Moreno J Avila U Leff P Anton B Heinze G Th2 cytokine response in Major Depressive Disorder patients before treatment J. Neuroimmunol 2006 172 156 165 16457895
  23. Pollmacher T Haack M Schuld A Reichenberg A Yirmiya R Low levels of circulating inflammatory cytokines—do they affect human brain functions? Brain Behav. Immun 2002 16 525 532 12401466
  24. Schleifer SJ Bartlett JA Keller SE Eckholdt HM Shiflett SC Delaney BR Immunity in adolescents with major depression J. Am. Acad. Child Adolesc. Psych 2002 41 1054 1060 12218426
  25. Shain BN Kronfol Z Naylor M Goel K Evans T Schaefer S Natural killer cell activity in adolescents with major depression Biol. Psychiatry 1991 29 481 484 2018821
  26. Simon NM McNamara K Chow CW Maser RS Papakostas GI Pollack MH Nierenberg AA Fava M Wong KK A detailed examination of cytokine abnormalities in Major Depressive Disorder Eur. Neuropsychopharmacol 2008 18 230 233 17681762 PMC2267745
  27. Sluzewska A Rybakowski JK Laciak M Mackiewicz A Sobieska M Wiktorowicz K Interleukin-6 serum levels in depressed patients before and after treatment with fluoxetine Ann. N. Y. Acad. Sci 1995 762 474 476 7668562
  28. Song C Lin A Bonaccorso S Heide C Verkerk R Kenis G Bosmans E Scharpe S Whelan A Cosyns P De Jongh R Maes M The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression J. Affect. Disord 1998 49 211 219 9629951
  29. Stone TW Darlington LG Endogenous kynurenines as targets for drug discovery and development Nat. Rev. Drug Discov 2002 1 609 620 12402501
  30. Tsao CW Lin YS Chen CC Bai CH Wu SR Cytokines and serotonin transporter in patients with major depression Prog. Neuro-Psychopharmacol. Biol. Psychiatry 2006 30 899 905 16616982
  31. Van Gool AR Fekkes D Kruit WH Mulder PG Ten Hagen TL Bannink M Maes M Eggermont AM Serum amino acids, biopterin and neopterin during long-term immunotherapy with interferon-alpha in high-risk melanoma patients Psychiatry Res 2003 119 125 132 12860366
  32. Weissman MM Wolk S Goldstein RB Moreau D Adams P Greenwald S Klier CM Ryan ND Dahl RE Wickramaratne P Depressed adolescents grown up J. Am. Med. Assoc 1999 281 1707 1713 10328070
  33. Wirleitner B Neurauter G Schrocksnadel K Frick B Fuchs D Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects Curr. Med. Chem 2003 10 1581 1591 12871129
  34. Yirmiya R Pollak Y Morag M Reichenberg A Barak O Avitsur R Shavit Y Ovadia H Weidenfeld J Morag A Newman ME Pollmacher T Illness, cytokines, and depression Ann. N. Y. Acad. Sci 2000 917 478 487 11268375

Authors
Gabbay, V., Klein, R. G., Alonso, C. M., Babb, J. S., Nishawala, M., De Jesus, G., Hirsch, G. S., Hottinger-Blanc, P. M. Z., & Gonzalez, C. J.
Affiliations
  • NYU Langone Health (US)
  • New York University (US)
  • New York State Department of Health (US)
Corresponding author
Gabbay, Vilma
Venue
Journal of Affective Disorders
Publisher
Elsevier BV
Published
2009-05
Volume
115
Issue
1-2
Pages
177-182
ISSN
0165-0327 (ISSN-L)
OpenAlex
W2037929058
Cited by
153
References
40
Citations by year
2026: 3 · 2025: 8 · 2024: 10 · 2023: 7 · 2022: 11 · 2021: 15 · 2020: 5 · 2019: 11 · 2018: 10 · 2017: 5 · 2016: 8 · 2015: 12 · 2014: 13 · 2013: 9 · 2012: 3
FWCI
2.56
Type
journal article
Language
en
Open access
Locations
  • Journal of Affective Disorders (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • American Foundation for Suicide Prevention
  • National Institute of Mental Health (MH077072, K23MH077072)
  • National Center for Research Resources (M01 RR 00096, M01RR000096)
  • National Center for Complementary and Integrative Health (R21AT002395, AT002395)
Topics
  • Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
  • Health Sciences › Medicine › Pharmacology › Treatment of Major Depression
Keywords
adolescent major depressive disorder, immune dysregulation, plasma cytokines, interferon-gamma, interleukin-6, Th1/Th2 imbalance, IFN-γ/IL-4 ratio, TNF-α, IL-1β, IL-4
MeSH terms
Adolescent, Child, Major Depressive Disorder, Depressive Disorder, Major, Enzyme-Linked Immunosorbent Assay, Female, Humans, Male, Reference Values, Cytokines, Th1 Cells, Th2 Cells, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review